FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10575811000001100: Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36035101000001116 Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36035201000001111 Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Is a Potassium dihydrogen phosphate + Sodium acid phosphate true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has active ingredient Sodium acid phosphate anhydrous false Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has active ingredient Monobasic potassium phosphate false Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has specific active ingredient Monobasic potassium phosphate true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has specific active ingredient Sodium acid phosphate anhydrous true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has active ingredient Monobasic sodium phosphate true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
K-Phos No.2 tablets (Beach Pharmaceuticals) Is a True Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Is pack of False Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has VMP True Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start